The impact of frailty on survival in elderly intensive care patients with COVID-19: the COVIP study
- PMID: 33874987
- PMCID: PMC8054503
- DOI: 10.1186/s13054-021-03551-3
The impact of frailty on survival in elderly intensive care patients with COVID-19: the COVIP study
Abstract
Background: The COVID-19 pandemic has led highly developed healthcare systems to the brink of collapse due to the large numbers of patients being admitted into hospitals. One of the potential prognostic indicators in patients with COVID-19 is frailty. The degree of frailty could be used to assist both the triage into intensive care, and decisions regarding treatment limitations. Our study sought to determine the interaction of frailty and age in elderly COVID-19 ICU patients.
Methods: A prospective multicentre study of COVID-19 patients ≥ 70 years admitted to intensive care in 138 ICUs from 28 countries was conducted. The primary endpoint was 30-day mortality. Frailty was assessed using the clinical frailty scale. Additionally, comorbidities, management strategies and treatment limitations were recorded.
Results: The study included 1346 patients (28% female) with a median age of 75 years (IQR 72-78, range 70-96), 16.3% were older than 80 years, and 21% of the patients were frail. The overall survival at 30 days was 59% (95% CI 56-62), with 66% (63-69) in fit, 53% (47-61) in vulnerable and 41% (35-47) in frail patients (p < 0.001). In frail patients, there was no difference in 30-day survival between different age categories. Frailty was linked to an increased use of treatment limitations and less use of mechanical ventilation. In a model controlling for age, disease severity, sex, treatment limitations and comorbidities, frailty was independently associated with lower survival.
Conclusion: Frailty provides relevant prognostic information in elderly COVID-19 patients in addition to age and comorbidities. Trial registration Clinicaltrials.gov: NCT04321265 , registered 19 March 2020.
Keywords: COVID-19; Elderly; Frailty; Outcome; Pandemia.
Conflict of interest statement
The authors declare that they have no competing interests. JCS reports grants (full departmental disclosure) from Orion Pharma, Abbott Nutrition International, B. Braun Medical AG, CSEM AG, Edwards Lifesciences Services GmbH, Kenta Biotech Ltd, Maquet Critical Care AB, Omnicare Clinical Research AG, Nestle, Pierre Fabre Pharma AG, Pfizer, Bard Medica S.A., Abbott AG, Anandic Medical Systems, Pan Gas AG Healthcare, Bracco, Hamilton Medical AG, Fresenius Kabi, Getinge Group Maquet AG, Dräger AG, Teleflex Medical GmbH, Glaxo Smith Kline, Merck Sharp and Dohme AG, Eli Lilly and Company, Baxter, Astellas, Astra Zeneca, CSL Behring, Novartis, Covidien, Philips Medical, Phagenesis Ltd, Prolong Pharmaceuticals and Nycomed outside the submitted work. The money went into departmental funds. No personal financial gain applied.
Figures


Comment in
-
The impact of frailty on survival in elderly intensive care patients with COVID‑19: do not dismiss intensive care unit overcrowding.Crit Care. 2021 Jun 30;25(1):225. doi: 10.1186/s13054-021-03653-y. Crit Care. 2021. PMID: 34193242 Free PMC article. No abstract available.
Similar articles
-
Differences in mortality in critically ill elderly patients during the second COVID-19 surge in Europe.Crit Care. 2021 Sep 23;25(1):344. doi: 10.1186/s13054-021-03739-7. Crit Care. 2021. PMID: 34556171 Free PMC article.
-
The impact of frailty on ICU and 30-day mortality and the level of care in very elderly patients (≥ 80 years).Intensive Care Med. 2017 Dec;43(12):1820-1828. doi: 10.1007/s00134-017-4940-8. Epub 2017 Sep 21. Intensive Care Med. 2017. PMID: 28936626
-
Sex-specific treatment characteristics and 30-day mortality outcomes of critically ill COVID-19 patients over 70 years of age-results from the prospective COVIP study.Can J Anaesth. 2022 Nov;69(11):1390-1398. doi: 10.1007/s12630-022-02304-2. Epub 2022 Aug 9. Can J Anaesth. 2022. PMID: 35945477 Free PMC article.
-
Association of frailty with outcomes in individuals with COVID-19: A living review and meta-analysis.J Am Geriatr Soc. 2021 Sep;69(9):2419-2429. doi: 10.1111/jgs.17299. Epub 2021 Jun 5. J Am Geriatr Soc. 2021. PMID: 34048599 Free PMC article.
-
Frailty and mortality associations in patients with COVID-19: a systematic review and meta-analysis.Intern Med J. 2022 May;52(5):724-739. doi: 10.1111/imj.15698. Epub 2022 Mar 21. Intern Med J. 2022. PMID: 35066970 Free PMC article.
Cited by
-
Clinical Manifestations and Outcomes of Older Patients with COVID-19: A Comprehensive Review.Tuberc Respir Dis (Seoul). 2024 Apr;87(2):145-154. doi: 10.4046/trd.2023.0157. Epub 2024 Feb 16. Tuberc Respir Dis (Seoul). 2024. PMID: 38368903 Free PMC article.
-
A new multi-national network studying Very old Intensive care Patients (VIPs).Anaesthesiol Intensive Ther. 2021;53(4):290-295. doi: 10.5114/ait.2021.108084. Anaesthesiol Intensive Ther. 2021. PMID: 35257561 Free PMC article.
-
The clinical frailty scale, but not the FRAIL checklist is associated with mortality in old critically ill patients with COVID-19.Crit Care. 2023 Mar 10;27(1):101. doi: 10.1186/s13054-023-04398-6. Crit Care. 2023. PMID: 36899440 Free PMC article. No abstract available.
-
Clinical Outcomes in Patients Aged 80 Years or Older Receiving Non-Invasive Respiratory Support for Hypoxemic Acute Respiratory Failure Consequent to COVID-19.J Clin Med. 2022 Mar 2;11(5):1372. doi: 10.3390/jcm11051372. J Clin Med. 2022. PMID: 35268463 Free PMC article.
-
Outcomes of patients aged ≥80 years with respiratory failure initially treated with non-invasive ventilation in European intensive care units before and during COVID-19 pandemic.Ann Intensive Care. 2023 Sep 12;13(1):82. doi: 10.1186/s13613-023-01173-2. Ann Intensive Care. 2023. PMID: 37698708 Free PMC article.
References
-
- Flaatten H, De Lange DW, Morandi A, Andersen FH, Artigas A, Bertolini G, Boumendil A, Cecconi M, Christensen S, Faraldi L, et al. The impact of frailty on ICU and 30-day mortality and the level of care in very elderly patients (>/= 80 years) Intensive Care Med. 2017;43(12):1820–1828. doi: 10.1007/s00134-017-4940-8. - DOI - PubMed
-
- Guidet B, de Lange DW, Boumendil A, Leaver S, Watson X, Boulanger C, Szczeklik W, Artigas A, Morandi A, Andersen F, et al. The contribution of frailty, cognition, activity of daily life and comorbidities on outcome in acutely admitted patients over 80 years in European ICUs: the VIP2 study. Intensive Care Med. 2020;46(1):57–69. doi: 10.1007/s00134-019-05853-1. - DOI - PMC - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical